Pulmonx is the developer of the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema.

Register for Details

For more details on financing and valuation for Pulmonx, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Pulmonx's ticker symbol?


What is Pulmonx's stock price?

10.25 as of 9/25/23

Learn more about Pulmonx

Forge green plus iconForge green minus icon

What is Pulmonx funding to date?

Pulmonx has raised $226.39MM to date.
Updated on: Jun 12, 2022